Revolution Medicines, Inc. Net Change in Cash increased by 131.1% to $57.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 127.3%, from -$209.51M to $57.19M. This is a positive signal — higher values indicate stronger performance for this metric.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$156.00M | -$66.45M | -$10.83M | $8.11M | $73.16M | $265.81M | -$46.04M | -$22.13M | $338.39M | -$407.72M | -$12.72M | -$74.59M | -$209.51M | $69.10M | -$184.05M | $57.19M |
| QoQ Change | — | +57.4% | +83.7% | +174.9% | +801.7% | +263.3% | -117.3% | +51.9% | >999% | -220.5% | +96.9% | -486.5% | -180.9% | +133.0% | -366.4% | +131.1% |
| YoY Change | — | — | — | +105.2% | +210.1% | >999% | -667.4% | -130.3% | — | -253.4% | +72.4% | -237.0% | +48.6% | +643.3% | -146.7% | +127.3% |